UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $417,000 | 0.0% | 47,900 | +9.1% | 0.00% | – |
| Q4 2021 | $417,000 | -43.5% | 43,900 | 0.0% | 0.00% | – |
| Q3 2021 | $738,000 | +10.1% | 43,900 | 0.0% | 0.00% | – |
| Q2 2021 | $670,000 | -19.1% | 43,900 | +3.3% | 0.00% | -100.0% |
| Q1 2021 | $828,000 | +8.1% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $766,000 | -6.6% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $820,000 | -21.2% | 42,500 | +6.8% | 0.00% | 0.0% |
| Q2 2020 | $1,040,000 | +69.1% | 39,800 | +15.4% | 0.00% | 0.0% |
| Q1 2020 | $615,000 | -45.8% | 34,500 | +1.5% | 0.00% | 0.0% |
| Q4 2019 | $1,135,000 | +41.7% | 34,000 | +1.2% | 0.00% | 0.0% |
| Q3 2019 | $801,000 | -30.8% | 33,600 | +4.3% | 0.00% | 0.0% |
| Q2 2019 | $1,157,000 | -2.7% | 32,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,189,000 | +51.7% | 32,200 | +76.9% | 0.00% | 0.0% |
| Q4 2018 | $784,000 | -3.4% | 18,200 | +5.8% | 0.00% | 0.0% |
| Q3 2018 | $812,000 | -5.1% | 17,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $856,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
| Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
| Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
| Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
| SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
| MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
| Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |